BJDX — Bluejay Diagnostics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1704287 ·
Last close
$2.15
Market Cap
$2.41M
52W High
$28.00
52W Low
$1.84
ADV30
46,296
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -2,349,124 | -2,324,013 | 11,533,900 | 9,598,916 | 2,119,060 |
| Mar 2026 | 0 | — | -1,938,831 | -1,919,241 | 5,598,603 | 3,684,457 | 1,417,408 |
| Dec 2025 | 0 | — | -1,461,747 | -1,429,812 | 7,119,237 | 5,164,875 | 1,143,948 |
| Sep 2025 | 0 | — | -1,616,947 | -1,597,632 | 4,890,258 | 3,082,268 | 1,197,476 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,903,219
Investing CF
$-331,822
Financing CF
$11,390,881
CapEx
$-161,762
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-12.75
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-45,760,521
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-7,315,012
Pretax Income TTM
$-7,270,698
Interest Exp TTM
$609
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -6,952,972 | -6,848,483 | 7,120,000 | 1,140,000 | 5,975,289 | -6,053,575 |
| Dec 2024 | 0 | -7,169,616 | -7,717,794 | 6,660,000 | 927,924 | 5,729,499 | -7,820,822 |
| Dec 2023 | 0 | -10,311,217 | -9,953,888 | 4,870,000 | 1,973,683 | 2,894,848 | -8,313,870 |
| Dec 2022 | 249,040 | -9,317,776 | -9,296,948 | 13,500,000 | 1,979,992 | 11,541,273 | -7,741,593 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$94,192
NetIncome TTM
$-7,270,698
OpCashFlow TTM
—
Assets (Latest)
$11,533,900
Forward EPS
$-0.32
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DROR | Dror Ortho-Design, Inc. | $2.44M | $0.00 | — |
| NUWE | Nuwellis, Inc. | $2.22M | $4.10 | — |
| AMIX | Autonomix Medical, Inc. | $2.21M | $1.08 | — |
| CODX | Co-Diagnostics, Inc. | $2.06M | $0.20 | — |
| ICCM | IceCure Medical Ltd. | $2.84M | $0.83 | — |
News headlines (Yahoo Finance, 1h cache)
Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-12 21:30 · Yahoo
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
2026-10-30 15:30 · Yahoo
Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness
2026-10-13 10:30 · Yahoo
Bluejay Diagnostics Advances Rapid Biomarker Testing For Sepsis Patients
2026-10-06 13:05 · Yahoo
Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock
2026-10-06 10:30 · Yahoo
Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance
2026-09-08 14:55 · Yahoo
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
2026-08-13 10:00 · Yahoo
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
2026-07-21 10:30 · Yahoo
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
2026-05-07 20:01 · Yahoo
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
2026-06-02 10:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.